HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells

Table 1 The clinical characteristics were compared between subtype 1 and subtype 2

characteristics total cases	N of case 994	Subtype		P value
characteristics total cases	N of case 994	Subtype 1 (N = 696)	Subtype 2 (N = 298)	P value
Age (years)
≤ 60	264	181	83	5.826E-01
> 60	715	504	211	5.826E-01
Geneder
Male	596	391	205	2.323E-04
Female	398	305	93	2.323E-04
Pathologic M
M0	738	512	226	6.918E-01
M1	31	23	8	6.918E-01
Pathologic N
N0	640	458	182	3.518E-01
N1	221	149	72
N2	109	70	39
N3	7	5	2
Pathologic T
T1	281	209	72	1.157E-01
T2	554	383	171
T3	115	77	38
T4	41	24	17
Pathologic stage
Stage I	510	375	135	1.508E-02
Stage II	277	188	89
Stage III	163	99	64
Stage IV	32	24	8
Ratiotherapy
Yes	110	79	31	9.980E-01
No	764	544	220	9.980E-01
Recurrence
Yes	251	180	71	9.331E-01
No	561	399	162	9.331E-01

ISSN: 1465-993X